So a $50 stock trading for $30....And we are worried about a decrease of a single drug is a portfolio of how many drugs?
Lattice, are you a short seller or hired by a team of short sellers?
Now, if this stock was trading at $50, I would understand the hyperfocus on a single declining drug sale in some markets but I think we need to expand the discussion to the entire portfolio if we are to take this seriously.
Does anyone have a good insider buying summary? The last reported ones are a bunch of grants at $34 last month. Was there some big insider buying in the fall?
In a past conference call, they seem ot indicate they might be able to finance smaller acquisition with cash flow? Any updates on this? There needs to be a catalyst to get investors excited. The talk of an acquisition did it so we now investors are eager and standing by it seems?
I see a few of these stocks continually show up as a top bullboard on stockhouse, is CXR a new top board? I don't recall seeing it in the top 10 that often? Unlike some of the sticky boards that always tend to show up?
Some very subtle bears here.... Knowing their motives would remove the credibility issues I have time some posters here. Fortunately, I haven't had to put too many people here on ignore.
Understanding bearish areas of concerns before taking too big of a position is important I think. But we need to avoid having the bashers point big bad spotlights on areas that get overblown. I sometimes feels posters are short seller spinning little things into big things.
Let's not forget, we are talking about a $30 stock right now, not a $50, $75 or $100+ stock!